Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union

P. Inacio, A. Cavaco, E. Allan, M. Airaksinen

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiPublic Health
Vuosikerta155
Sivut119-128
Sivumäärä10
ISSN0033-3506
DOI - pysyväislinkit
TilaJulkaistu - helmikuuta 2018
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3142 Kansanterveystiede, ympäristö ja työterveys

Lainaa tätä

@article{f9b41fbd7588446fa6175dd180805ba9,
title = "Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union",
keywords = "Pharmacovigilance, Spontaneous reporting, Patient-reported adverse drug reactions, Risk management, European Union, QUALITATIVE RESEARCH, RISK-MANAGEMENT, MEDICINES, INFORMATION, INVOLVEMENT, SYSTEM, HEALTH, SAFETY, 3142 Public health care science, environmental and occupational health",
author = "P. Inacio and A. Cavaco and E. Allan and M. Airaksinen",
year = "2018",
month = "2",
doi = "10.1016/j.puhe.2017.11.023",
language = "English",
volume = "155",
pages = "119--128",
journal = "Public Health",
issn = "0033-3506",
publisher = "W.B. Saunders",

}

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union. / Inacio, P.; Cavaco, A.; Allan, E.; Airaksinen, M.

julkaisussa: Public Health, Vuosikerta 155, 02.2018, s. 119-128.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union

AU - Inacio, P.

AU - Cavaco, A.

AU - Allan, E.

AU - Airaksinen, M.

PY - 2018/2

Y1 - 2018/2

KW - Pharmacovigilance

KW - Spontaneous reporting

KW - Patient-reported adverse drug reactions

KW - Risk management

KW - European Union

KW - QUALITATIVE RESEARCH

KW - RISK-MANAGEMENT

KW - MEDICINES

KW - INFORMATION

KW - INVOLVEMENT

KW - SYSTEM

KW - HEALTH

KW - SAFETY

KW - 3142 Public health care science, environmental and occupational health

U2 - 10.1016/j.puhe.2017.11.023

DO - 10.1016/j.puhe.2017.11.023

M3 - Article

VL - 155

SP - 119

EP - 128

JO - Public Health

JF - Public Health

SN - 0033-3506

ER -